213 related articles for article (PubMed ID: 30986539)
1. Methyl aminolevulinate-based photodynamic therapy of Bowen´s disease: Observational study of 21 lesions.
Gómez C; Cobos M; Alberdi E
Photodiagnosis Photodyn Ther; 2019 Jun; 26():295-299. PubMed ID: 30986539
[TBL] [Abstract][Full Text] [Related]
2. Interventions for cutaneous Bowen's disease.
Bath-Hextall FJ; Matin RN; Wilkinson D; Leonardi-Bee J
Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD007281. PubMed ID: 23794286
[TBL] [Abstract][Full Text] [Related]
3. Photodynamic therapy in the treatment of extensive Bowen's disease.
López N; Meyer-Gonzalez T; Herrera-Acosta E; Bosch R; Castillo R; Herrera E
J Dermatolog Treat; 2012 Dec; 23(6):428-30. PubMed ID: 21787214
[TBL] [Abstract][Full Text] [Related]
4. Ablative fractional laser-assisted photodynamic therapy provides superior long-term efficacy compared with standard methyl aminolevulinate photodynamic therapy for lower extremity Bowen disease.
Kim HJ; Song KH
J Am Acad Dermatol; 2018 Nov; 79(5):860-868. PubMed ID: 29857012
[TBL] [Abstract][Full Text] [Related]
5. Methylaminolaevulinate-based photodynamic therapy of Bowen's disease and squamous cell carcinoma.
Calzavara-Pinton PG; Venturini M; Sala R; Capezzera R; Parrinello G; Specchia C; Zane C
Br J Dermatol; 2008 Jul; 159(1):137-44. PubMed ID: 18489606
[TBL] [Abstract][Full Text] [Related]
6. The France-PDT study: a national prospective observational cohort survey on the use of methyl-aminolevulinate photodynamic therapy in France, with up to 6-month follow-up.
Farhi D; Bedane C; Savary J; Basset-Seguin N
Eur J Dermatol; 2013; 23(1):68-76. PubMed ID: 23400280
[TBL] [Abstract][Full Text] [Related]
7. Methyl aminolevulinate: actinic keratoses and Bowen's disease.
Morton CA
Dermatol Clin; 2007 Jan; 25(1):81-7. PubMed ID: 17126745
[TBL] [Abstract][Full Text] [Related]
8. Methyl-aminolevulinate photodynamic therapy for the treatment of actinic keratoses and non-melanoma skin cancers: a retrospective analysis of response in 462 patients.
Fai D; Arpaia N; Romano I; Vestita M; Cassano N; Vena GA
G Ital Dermatol Venereol; 2009 Jun; 144(3):281-5. PubMed ID: 19528909
[TBL] [Abstract][Full Text] [Related]
9. A randomized trial comparing methyl aminolaevulinate photodynamic therapy with and without Er:YAG ablative fractional laser treatment in Asian patients with lower extremity Bowen disease: results from a 12-month follow-up.
Ko DY; Kim KH; Song KH
Br J Dermatol; 2014 Jan; 170(1):165-72. PubMed ID: 24102369
[TBL] [Abstract][Full Text] [Related]
10. Treatment of Bowen's disease with photodynamic therapy. Observational study in 171 patients with 5-aminolaevulinic acid (BF-200 ALA) and methyl aminolaevulinate (MAL).
Alique-García S; Alique D; Company-Quiroga J; Sánchez A; Núñez AH; Borbujo J
Photodiagnosis Photodyn Ther; 2019 Dec; 28():192-194. PubMed ID: 31398515
[TBL] [Abstract][Full Text] [Related]
11. A cost analysis of photodynamic therapy with methyl aminolevulinate and imiquimod compared with conventional surgery for the treatment of superficial basal cell carcinoma and Bowen's disease of the lower extremities.
Aguilar M; de Troya M; Martin L; Benítez N; González M
J Eur Acad Dermatol Venereol; 2010 Dec; 24(12):1431-6. PubMed ID: 20456549
[TBL] [Abstract][Full Text] [Related]
12. Methyl aminolevulinate-PDT for actinic keratoses and superficial nonmelanoma skin cancers.
Ortiz-Policarpio B; Lui H
Skin Therapy Lett; 2009; 14(6):1-3. PubMed ID: 19609473
[TBL] [Abstract][Full Text] [Related]
13. Long-term efficacy of photodynamic therapy with methyl aminolevulinate in treating Bowen's disease in clinical practice: A retrospective cohort study (2006-2017).
Aguilar-Bernier M; Rodríguez-Barón D; Rivas-Ruiz F; Segura-Palacios JM; de Troya Martín M
Photodermatol Photoimmunol Photomed; 2019 Jul; 35(4):208-213. PubMed ID: 30690796
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of photodynamic therapy with topical 5-aminolevulinic acid using intense pulsed light for Bowen's disease.
Hasegawa T; Suga Y; Mizuno Y; Haruna K; Ogawa H; Ikeda S
J Dermatol; 2010 Jul; 37(7):623-8. PubMed ID: 20629828
[TBL] [Abstract][Full Text] [Related]
15. Photodynamic therapy with epidermal ablation using fractional carbon-dioxide laser in the treatment of Bowen's disease: A case series.
Sung JM; Kim YC
Photodiagnosis Photodyn Ther; 2017 Sep; 19():84-85. PubMed ID: 28457851
[TBL] [Abstract][Full Text] [Related]
16. Surgical excision versus topical 5% 5-fluorouracil and photodynamic therapy in treatment of Bowen's disease: A multicenter randomized controlled trial.
Ahmady S; Nelemans PJ; Kelleners-Smeets NWJ; Arits AHMM; de Rooij MJM; Kessels JPHM; Essers BAB; Mosterd K
J Am Acad Dermatol; 2024 Jan; 90(1):58-65. PubMed ID: 37666424
[TBL] [Abstract][Full Text] [Related]
17. Long-term follow-up of metil aminolevulinate (MAL)-PDT in difficult-to-treat cutaneous Bowen's disease.
Cavicchini S; Serini SM; Fiorani R; Girgenti V; Ghislanzoni M; Sala F
Int J Dermatol; 2011 Aug; 50(8):1002-5. PubMed ID: 21781078
[TBL] [Abstract][Full Text] [Related]
18. Photodynamic therapy for subungual Bowen's disease.
Tan B; Sinclair R; Foley P
Australas J Dermatol; 2004 Aug; 45(3):172-4. PubMed ID: 15250896
[TBL] [Abstract][Full Text] [Related]
19. Long-term recurrence of nonmelanoma skin cancer after topical methylaminolevulinate photodynamic therapy in a dermato-oncology department.
Cabete J; Rafael M; Cravo M; Moura C; Sachse F; Pecegueiro M
An Bras Dermatol; 2015; 90(6):846-50. PubMed ID: 26734866
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of photodynamic therapy in Bowen's disease: an observational and descriptive study in 51 lesions.
Truchuelo M; Fernández-Guarino M; Fleta B; Alcántara J; Jaén P
J Eur Acad Dermatol Venereol; 2012 Jul; 26(7):868-74. PubMed ID: 21740466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
